Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
The Journal of Rheumatology. Supplement
|
June 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
Ying Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology
|
May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group
Alexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology
|
December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
The Journal of Rheumatology
|
February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report
Alí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
The Journal of Rheumatology
|
June 17, 2015
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures
Jennifer Petkovic, Jonathan Epstein, Rachelle Buchbinder, et al.
The Journal of Rheumatology
|
August 3, 2017
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016
Linda A Rasch, Maarten Boers, Catherine L Hill, et al.
Current Medical Research and Opinion
|
December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA
Josef S Smolen, Maarten Boers, Eric C Abadie, et al.
The Journal of Rheumatology
|
September 17, 2015
Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda
Lara J Maxwell, George A Wells, Lee S Simon, et al.
The Journal of Rheumatology
|
May 3, 2017
Proceedings of the GRAPPA 2016 Retreat
Deepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
Seminars in Arthritis and Rheumatism
|
July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report
Bethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
The Journal of Rheumatology. Supplement
|
June 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group
Ying Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology
|
May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group
Alexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology
|
December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
The Journal of Rheumatology
|
February 17, 2019
Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report
Alí Duarte-García, Ying Ying Leung, Laura C Coates, et al.
The Journal of Rheumatology
|
June 17, 2015
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures
Jennifer Petkovic, Jonathan Epstein, Rachelle Buchbinder, et al.
The Journal of Rheumatology
|
August 3, 2017
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016
Linda A Rasch, Maarten Boers, Catherine L Hill, et al.
Current Medical Research and Opinion
|
December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA
Josef S Smolen, Maarten Boers, Eric C Abadie, et al.
The Journal of Rheumatology
|
September 17, 2015
Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda
Lara J Maxwell, George A Wells, Lee S Simon, et al.
The Journal of Rheumatology
|
May 3, 2017
Proceedings of the GRAPPA 2016 Retreat
Deepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
Seminars in Arthritis and Rheumatism
|
July 19, 2021
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report
Bethan Jones, Caroline A Flurey, Susanna Proudman, et al.
Page
of 10